Topiroxostat

Topithostat has a aggressive inhibitory impact on xanthine oxidoreductase, thereby inhibiting uric acid production. There is no blocking off impact on different pyrimidine purine metabolic enzymes, however selective blocking off impact on xanthine oxidoreductase. Topithostat has a full-size inhibitory impact on each oxidative and decreased XOR, making its uric acid reducing impact greater effective and long-lasting. Therefore, this product can be used to deal with persistent hyperuricemia triggered by means of gout.